Rivastigmine tartrate is a potent acetylcholinesterase inhibitor indicated for the treatment of mild to moderate dementia associated with Alzheimer's disease and Parkinson's disease, functioning by inhibiting… Read more













Rivastigmine tartrate is a potent acetylcholinesterase inhibitor indicated for the treatment of mild to moderate dementia associated with Alzheimer's disease and Parkinson's disease, functioning by inhibiting enzymes that break down the neurotransmitter acetylcholine. In analytical laboratories, consistent quality control requires precise reference standards for the active ingredient, alongside its related degradation products and synthetic by-products. These materials are vital for comprehensive impurity profiling, enabling researchers to identify, qualify, and quantify potential contaminants throughout the manufacturing process. Furthermore, stable isotope labelled versions of the compound serve as essential internal standards for high-accuracy quantitative analysis, particularly in bioanalytical method validation and pharmacokinetic studies. By providing access to these specialized compounds, this catalogue supports the rigorous analytical testing necessary to ensure pharmaceutical safety and regulatory compliance during both drug development and routine quality assessment.